CytomX Therapeutics, Inc. - Common Stock (CTMX)
CUSIP: 23284F105
Q3 2019 13F Holders as of 30 Sep 2019
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 169,491,059
- Total 13F shares
- 35,837,109
- Share change
- +188,645
- Total reported value
- $264,433,175
- Price per share
- $7.38
- Number of holders
- 111
- Value change
- -$1,377,891
- Number of buys
- 58
- Number of sells
- 48
Quarterly Holders Quick Answers
What is CUSIP 23284F105?
CUSIP 23284F105 identifies CTMX - CytomX Therapeutics, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 23284F105:
Top shareholders of CTMX - CytomX Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock Finance, Inc. |
13F
|
Company |
2.3%
|
3,890,049
|
$43,647,000 | — | 30 Jun 2019 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
2%
|
3,320,557
|
$37,257,000 | — | 30 Jun 2019 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
1.9%
|
3,153,923
|
$35,387,000 | — | 30 Jun 2019 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
1.7%
|
2,800,872
|
$31,426,000 | — | 30 Jun 2019 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.6%
|
2,671,374
|
$29,973,000 | — | 30 Jun 2019 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
1.2%
|
1,985,990
|
$22,283,000 | — | 30 Jun 2019 | |
| BVF INC/IL |
13F
|
Company |
1.1%
|
1,873,617
|
$21,022,000 | — | 30 Jun 2019 | |
| STATE STREET CORP |
13F
|
Company |
1%
|
1,733,453
|
$19,449,000 | — | 30 Jun 2019 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.83%
|
1,407,000
|
$15,787,000 | — | 30 Jun 2019 | |
| FMR LLC |
13F
|
Company |
0.78%
|
1,323,211
|
$14,847,000 | — | 30 Jun 2019 | |
| RTW INVESTMENTS, LP |
13F
|
Company |
0.58%
|
988,319
|
$11,089,000 | — | 30 Jun 2019 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.44%
|
744,400
|
$8,352,000 | — | 30 Jun 2019 | |
| S.c.a. Candriam |
13F
|
Individual |
0.41%
|
687,833
|
$7,684,000 | — | 30 Jun 2019 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.35%
|
598,991
|
$6,720,000 | — | 30 Jun 2019 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.32%
|
546,078
|
$6,127,000 | — | 30 Jun 2019 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.28%
|
474,838
|
$5,328,000 | — | 30 Jun 2019 | |
| Spark Investment Management LLC |
13F
|
Company |
0.26%
|
432,981
|
$4,858,000 | — | 30 Jun 2019 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.24%
|
406,357
|
$4,559,000 | — | 30 Jun 2019 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.21%
|
349,194
|
$3,917,000 | — | 30 Jun 2019 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.2%
|
332,194
|
$3,727,000 | — | 30 Jun 2019 | |
| MORGAN STANLEY |
13F
|
Company |
0.2%
|
331,094
|
$3,715,000 | — | 30 Jun 2019 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.19%
|
330,498
|
$3,708,000 | — | 30 Jun 2019 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.17%
|
283,310
|
$3,176,000 | — | 30 Jun 2019 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.16%
|
264,071
|
$2,963,000 | — | 30 Jun 2019 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.15%
|
253,200
|
$2,841,000 | — | 30 Jun 2019 | |
| PRUDENTIAL FINANCIAL INC |
13F
|
Company |
0.14%
|
235,272
|
$2,640,000 | — | 30 Jun 2019 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
0.11%
|
194,377
|
$2,181,000 | — | 30 Jun 2019 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.11%
|
181,762
|
$2,040,000 | — | 30 Jun 2019 | |
| Allianz Asset Management GmbH |
13F
|
Company |
0.11%
|
180,653
|
$2,026,000 | — | 30 Jun 2019 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.1%
|
167,987
|
$1,885,000 | — | 30 Jun 2019 | |
| Congress Park Capital LLC |
13F
|
Company |
0.1%
|
168,611
|
$1,716,000 | — | 30 Jun 2019 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.09%
|
149,842
|
$1,682,000 | — | 30 Jun 2019 | |
| Private Advisor Group, LLC |
13F
|
Company |
0.09%
|
147,270
|
$1,652,000 | — | 30 Jun 2019 | |
| Granahan Investment Management, LLC |
13F
|
Company |
0.09%
|
147,223
|
$1,652,000 | — | 30 Jun 2019 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.08%
|
134,457
|
$1,509,000 | — | 30 Jun 2019 | |
| UNITED SERVICES AUTOMOBILE ASSOCIATION |
13F
|
Company |
0.08%
|
134,001
|
$1,503,000 | — | 30 Jun 2019 | |
| MOORE CAPITAL MANAGEMENT, LP |
13F
|
Company |
0.07%
|
125,000
|
$1,403,000 | — | 30 Jun 2019 | |
| Assenagon Asset Management S.A. |
13F
|
Company |
0.07%
|
124,400
|
$1,396,000 | — | 30 Jun 2019 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.08%
|
127,293
|
$1,351,000 | — | 30 Jun 2019 | |
| Exane Asset Management |
13F
|
Company |
0.06%
|
107,000
|
$1,200,540 | — | 30 Jun 2019 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.06%
|
100,512
|
$1,127,000 | — | 30 Jun 2019 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.06%
|
94,724
|
$1,063,000 | — | 30 Jun 2019 | |
| Fosun International Ltd |
13F
|
Company |
0.06%
|
97,457
|
$1,035,000 | — | 30 Jun 2019 | |
| CITIGROUP INC |
13F
|
Company |
0.05%
|
91,988
|
$1,032,000 | — | 30 Jun 2019 | |
| Swiss National Bank |
13F
|
Company |
0.05%
|
83,900
|
$941,000 | — | 30 Jun 2019 | |
| HARBOURVEST PARTNERS LLC |
13F
|
Company |
0.05%
|
79,193
|
$889,000 | — | 30 Jun 2019 | |
| KENNEDY CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.04%
|
75,507
|
$847,000 | — | 30 Jun 2019 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.04%
|
73,151
|
$821,000 | — | 30 Jun 2019 | |
| Rafferty Asset Management, LLC |
13F
|
Company |
0.04%
|
72,641
|
$815,000 | — | 30 Jun 2019 | |
| A.R.T. Advisors, LLC |
13F
|
Company |
0.04%
|
72,291
|
$811,000 | — | 30 Jun 2019 |
Institutional Holders of CytomX Therapeutics, Inc. - Common Stock (CTMX) as of Q3 2019
As of 30 Sep 2019,
CytomX Therapeutics, Inc. - Common Stock (CTMX) was held by
111 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
35,837,109 shares.
The largest 10 holders included
WELLINGTON MANAGEMENT GROUP LLP, BlackRock Inc., PERCEPTIVE ADVISORS LLC, VICTORY CAPITAL MANAGEMENT INC, VANGUARD GROUP INC, PRICE T ROWE ASSOCIATES INC /MD/, BVF INC/IL, STATE STREET CORP, RENAISSANCE TECHNOLOGIES LLC, and RTW INVESTMENTS, LP.
This page lists
111
institutional shareholders reporting positions in this security
for the Q3 2019 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2019 vs Q2 2019 Across Filers
Q2 2019 holders
108
Q3 2019 holders
111
Holder diff
3
| Investor | Q2 2019 Shares | Q3 2019 Shares | Share Diff | Share Chg % | Q2 2019 Value $ | Q3 2019 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.